Research Appraisalother

A Multiassessment and Multiprofessional Agents Approach for Medical Chatbot Risk Estimation: Development and Evaluation Study

JMIR medical informaticsTamayo, Lenard Paulo Velasco, Nishiyama, Tomohiro, Peng, Shaowen et al.15 May 2026DOI

Clinical Snapshot

80CEBM
Evidence: Moderateother

PICO Framework

P — PopulationMedical chatbot responses requiring risk assessment across medical, ethical, and legal domains
I — InterventionMultiassessment and multiprofessional agents (MA-MPA) framework with retrieval-augmented generation
C — ComparatorBaseline large language models, enhanced prompts, and existing NTCIR-18 MedNLP-CHAT systems
O — OutcomesMacro F1-score, joint accuracy across risk domains, and performance improvements in medical, ethical, and legal risk assessment

Bottom Line

This technology development study presents a promising framework for assessing risks in medical chatbot responses across medical, ethical, and legal domains. The MA-MPA approach achieved notable improvements in ethical and legal risk assessment compared to existing systems, though medical domain improvements were modest. While the methodology is sound and results encouraging, the study's limitations include small sample size, unclear real-world applicability, and lack of cost-effectiveness analysis. For Australian healthcare settings, this technology could support TGA compliance for AI medical devices and enhance patient safety in digital health applications, but would require local validation and integration with existing clinical workflows before implementation.

Evidence: Moderate

Key Findings

  • P Value: Not explicitly reported

  • Effect Size: Ethical domain improvement: +0.252, Legal domain: +0.096, Medical domain: +0.070

  • Primary Outcome: Macro F1-score across risk domains: 0.800 for MA-MPA with RAG

  • Nnt Or Sensitivity: Joint accuracy: 60.3% (76/126 correct predictions across all domains)

  • Confidence Interval: MPA gain: +0.037 (95% CI 0.003-0.074)

Clinical Application

Requires significant computational resources and specialized LLM infrastructure, limiting immediate clinical deployment Relevant for TGA AI medical device regulations and RACGP digital health guidelines, though implementation would require local validation and compliance assessment Healthcare organizations implementing AI chatbots for patient interaction and clinical decision support

Abstract

BACKGROUND: Assessing chatbot responses across 3 domains-medical, ethical, and legal-is essential to ensuring the safe use of artificial intelligence in health care. Although advancements in the use of large language models (LLMs) show significant improvements in evaluating question-answer datasets, such as multiple-choice medical exams, existing systems use general LLMs without incorporating specialized domain knowledge. They rely on standardized instructions without integrating real-world information, and ensemble methods such as majority voting fail to resolve disagreements among agents, resulting in misclassification and challenges in risk assessment. OBJECTIVE: This study aims to design, develop, and evaluate a synergistic approach for assessing risks associated with chatbot responses using multiassessment (MA) and multiprofessional agents (MPAs). METHODS: We designed and developed an approach consisting of MA and MPA, specifically initial assessment (MA1), which internalizes 3 roles and provides an initial risk estimation, and final assessment (MA3), which aims to reach a final consensus based on the previous assessments (MA1 and MA2), with each using 1 LLM. The verification assessment (MA2) incorporates an MPA or role-based LLM specialized agents for each risk domain (medical, ethical, and legal). We evaluated the proposed approach using the MedNLP-CHAT (Medical Natural Language Processing for AI Chat) corpus (N=226; 100 train, 126 test), covering baseline, enhanced prompt, embedding-based search, and retrieval-augmented generation (RAG). Primary metrics included macro F1-score and joint accuracy to evaluate system performance, along with CI and paired macro F1-score difference (Δ) as supporting metrics to assess the approach's effectiveness. RESULTS: The MA-MPA framework integrated with RAG achieved the highest average macro F1-score of 0.800 across risk domains and a joint accuracy of 76 (60.3%) correct predictions across all risk domains out of 126 question-answer pairs, with notable improvements over the best reported Eighteenth NII Testbeds and Community for Information Access Research Project (NTCIR-18) MedNLP-CHAT systems in the ethical (+0.252) and legal (+0.096) risk domains, while the medical domain showed a modest increase of +0.070. The MA approach contributed the largest gains, particularly from MA1 to MA2, with paired macro F1-score gains ranging from +0.176 to +0.214 across systems. The MPA approach performed better when integrated with MA and external knowledge, with paired bootstrap estimates showing a gain of +0.037 (95% CI 0.003-0.074) over baseline; however, joint accuracy gains were not evident (95% CI -2.9% to 7.7%), and gains relative to the enhanced prompt were small. Notably, MA alone achieved higher joint accuracy than RAG (62.7% vs 60.3%), indicating a metric-specific trade-off rather than consistent superiority across all metrics. CONCLUSIONS: The MA-MPA approach shows potential for improving risk estimation in chatbot responses. The results suggest that the framework is particularly useful for enhancing balanced overall performance, especially when combined with external knowledge, although the medical risk domain remains challenging. Furthermore, more specialized LLMs may further improve contextually grounded risk estimation.

References

  1. 1.Tamayo, L. P. V., Nishiyama, T., Peng, S., Wakamiya, S., & Aramaki, E. (2026). A Multiassessment and Multiprofessional Agents Approach for Medical Chatbot Risk Estimation: Development and Evaluation Study. JMIR Medical Informatics, 12(1), e80416. https://doi.org/10.2196/80416
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service